This inventor holds 1 USPTO granted patent. Top assignee: Gwangju Institute of Science and Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Hyun-Jun Kim in Muscle Atrophy Treatment
Introduction
Hyun-Jun Kim is an accomplished inventor based in Jeonju, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of skeletal muscle atrophy. His innovative work focuses on the development of compositions that can effectively prevent and treat muscle loss.
Latest Patents
Hyun-Jun Kim holds a patent for a composition comprising an organoselenium compound aimed at treating skeletal muscle atrophy. This application relates to a composition designed to prevent, treat, and improve muscle atrophy, which includes an organoselenium compound. The composition has demonstrated the ability to recover the thickness of muscle fibers that are reduced by dexamethasone treatment. Furthermore, studies conducted on mice in a muscle loss model have shown that this composition effectively reduces damaged muscle and restores muscle mass. Therefore, it is anticipated that this composition can be effectively utilized for the treatment, prevention, or improvement of muscle atrophy.
Career Highlights
Hyun-Jun Kim is affiliated with the Gwangju Institute of Science and Technology, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on health and wellness, particularly for individuals suffering from muscle atrophy.
Collaborations
Hyun-Jun Kim collaborates with notable colleagues, including Da-Woon Jung and Ji-Hyung Lee, who contribute to his research endeavors and innovations.
Conclusion
Hyun-Jun Kim's innovative contributions to the treatment of skeletal muscle atrophy highlight the importance of research in medical science. His work not only advances scientific knowledge but also holds promise for improving the quality of life for those affected by muscle loss.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile